Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
CryoPort
CYRX
$761M
| $643K | ﹤0.01% |
58,230
| – | – |
|
2677
Daily Journal
DJCO
$809M
| $641K | ﹤0.01% |
2,738
+346
| +14% | +$81.4K |
|
2678
Digi International
DGII
$2.63B
| $637K | ﹤0.01% |
63,091
+3,601
| +6% | +$41.6K |
|
|
ORBK
2679
DELISTED
Orbotech Ltd
ORBK
| $637K | ﹤0.01% |
11,250
+3,489
| +45% | +$195K |
|
|
CMRX
2680
DELISTED
Chimerix, Inc.
CMRX
| $636K | ﹤0.01% |
247,411
-2,444
| -1% | -$8.18K |
|
2681
Corbus Pharmaceuticals
CRBP
$166M
| $633K | ﹤0.01% |
3,612
-40
| -1% | -$7.98K |
|
2682
Capital City Bank Group
CCBG
$888M
| $632K | ﹤0.01% |
27,207
| – | – |
|
2683
Standard BioTools
LAB
$340M
| $632K | ﹤0.01% |
73,219
+13,419
| +22% | +$105K |
|
2684
Sterling Infrastructure
STRL
$18.3B
| $631K | ﹤0.01% |
57,934
-18,247
| -24% | -$222K |
|
2685
Southern Missouri Bancorp
SMBC
$852M
| $630K | ﹤0.01% |
18,565
+3,410
| +23% | +$119K |
|
|
CCRN
2686
DELISTED
Cross Country Healthcare
CCRN
| $628K | ﹤0.01% |
85,557
+4,342
| +5% | +$36.4K |
|
|
NETI
2687
DELISTED
Eneti Inc.
NETI
| $627K | ﹤0.01% |
12,191
| – | – |
|
2688
Western New England Bancorp
WNEB
$259M
| $625K | ﹤0.01% |
62,229
+2,500
| +4% | +$24.8K |
|
2689
First Bancorp
FNLC
$396M
| $623K | ﹤0.01% |
23,661
+1,067
| +5% | +$29.6K |
|
2690
Twist Bioscience
TWST
$5.7B
| $622K | ﹤0.01% |
+26,919
| New | +$597K |
|
|
CURO
2691
DELISTED
CURO Group Holdings Corp.
CURO
| $622K | ﹤0.01% |
65,497
-3,047
| -4% | -$49.9K |
|
2692
Arlo Technologies
ARLO
$1.6B
| $619K | ﹤0.01% |
61,990
-492
| -0.8% | -$5.9K |
|
|
NVTR
2693
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $617K | ﹤0.01% |
37,703
+7,670
| +26% | +$147K |
|
2694
ACNB Corp
ACNB
$656M
| $615K | ﹤0.01% |
15,645
+1,095
| +8% | +$41.4K |
|
2695
Artesian Resources
ARTNA
$355M
| $614K | ﹤0.01% |
17,606
+506
| +3% | +$18.2K |
|
2696
Primis Financial Corp
FRST
$399M
| $612K | ﹤0.01% |
46,238
+3,138
| +7% | +$47.3K |
|
|
CHMI
2697
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $611K | ﹤0.01% |
34,818
+570
| +2% | +$10.4K |
|
2698
Home Bancorp
HBCP
$561M
| $611K | ﹤0.01% |
17,246
+600
| +4% | +$23.2K |
|
|
STML
2699
DELISTED
Stemline Therapeutics, Inc.
STML
| $611K | ﹤0.01% |
64,291
-264
| -0.4% | -$3.42K |
|
2700
Biglari Holdings Class B
BH
$1.25B
| $610K | ﹤0.01% |
5,370
-76
| -1% | -$11.2K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.